A groundbreaking weight loss invention could soon make it possible to drop those extra pounds without a single change in your diet.

Just 800 of the 13,500 patients eligible to start receiving Wegovy, which can help obese people lose 15% of their body weight ...

The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

Groundbreaking research presented at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) that ...

Lilly’s latest investment comes on the heels of three earlier rounds of manufacturing investment at the LEAP Research and ...

Researchers have unveiled a novel approach to tackle obesity by targeting fat absorption in the small intestine. The ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Doctors have said access to the drug is a "postcode lottery" as Sky News analysis reveals just 800 people have been ...

Three Fool.com contributors have identified what they believe are no-brainer growth stocks to buy in October. Here's why they picked Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Vertex ...